Add BrightSurf on Google Email

Science News for September 15, 1997


UT-Houston Awarded $2.5 Million For Scleroderma Research

The University of Texas-Houston has established a Specialized Center of Research (SCOR) in scleroderma, a chronic disease with no known effective treatment or prevention. The center will conduct investigations into the genetic and environmental factors that affect susceptibility to the disease.

SourceUniversity of Texas Health Science Center at Houston·DateSep 15, 1997

Frustrating Patients Likely To Be Unmarried

A study by psychiatrists at the University of Washington Medical Center found that unmarried patients were more likely to evoke strong reactions from physicians, with multiple unexplainable physical symptoms and a history of trauma being key indicators.

SourceCenter for Advancing Health·JournalGeneral Hospital Psychiatry·DateSep 15, 1997
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Duke Researchers Show How Hepatitis Infection Leads To Liver Cancer

Researchers at Duke University Medical Center found that a hepatitis infection converts the liver into a 'cancer time bomb' by converting it into billions of cancer-prone cells. The virus makes even apparently healthy cells lose one of two copies of a protective tumor suppressor gene, making them vulnerable to further genetic damage.

SourceDuke University Medical Center·JournalProceedings of the National Academy of Sciences·DateSep 15, 1997

Mutant Gene Not Sole Explanation For Hiv Non-Progression

A recent study found that a genetic mutation in the CCR5 gene does not fully explain why some people infected with HIV remain healthy for years. Instead, researchers attribute their good health to various factors, including immune system components and viral factors. The investigation involved 33 patients from different cohorts and rev...

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalJournal of Clinical Investigation·DateSep 15, 1997